GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 327 filers reported holding GW PHARMACEUTICALS PLC in Q2 2019. The put-call ratio across all filers is 1.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $2,193,000 | +21.8% | 17,908 | -13.1% | 0.01% | 0.0% |
Q1 2020 | $1,800,000 | -38.6% | 20,598 | -26.7% | 0.01% | -22.2% |
Q4 2019 | $2,933,000 | +20.8% | 28,088 | +32.9% | 0.01% | +50.0% |
Q3 2019 | $2,427,000 | -10.0% | 21,128 | +35.1% | 0.01% | -33.3% |
Q2 2019 | $2,697,000 | +104.0% | 15,641 | +99.2% | 0.01% | +125.0% |
Q1 2019 | $1,322,000 | +4.7% | 7,852 | +7.4% | 0.00% | 0.0% |
Q4 2018 | $1,263,000 | 0.0% | 7,314 | 0.0% | 0.00% | -20.0% |
Q3 2018 | $1,263,000 | +49.6% | 7,314 | +21.0% | 0.01% | +66.7% |
Q2 2018 | $844,000 | +257.6% | 6,046 | +187.6% | 0.00% | +200.0% |
Q1 2018 | $236,000 | +3271.4% | 2,102 | +3653.6% | 0.00% | – |
Q4 2017 | $7,000 | +40.0% | 56 | +9.8% | 0.00% | – |
Q3 2017 | $5,000 | -66.7% | 51 | -66.2% | 0.00% | – |
Q2 2017 | $15,000 | -37.5% | 151 | -24.5% | 0.00% | – |
Q1 2017 | $24,000 | – | 200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 450,000 | $55,224,000 | 4.41% |
Parkman Healthcare Partners LLC | 119,778 | $14,699,000 | 4.14% |
Sio Capital Management, LLC | 94,984 | $11,656,000 | 3.40% |
Tamarack Advisers, LP | 90,000 | $11,045,000 | 3.08% |
Copernicus Capital Management, LLC | 22,000 | $2,700,000 | 2.96% |
Integral Health Asset Management, LLC | 75,000 | $9,204,000 | 2.76% |
ETF MANAGERS GROUP, LLC | 480,145 | $58,923,000 | 2.09% |
AdvisorShares Investments LLC | 29,758 | $3,652,000 | 1.55% |
Redwood Investments, LLC | 130,444 | $16,008,000 | 1.42% |
CLOUGH CAPITAL PARTNERS L P | 100,746 | $12,364,000 | 1.21% |